Page last updated: 2024-10-22

arotinolol and Graves Disease

arotinolol has been researched along with Graves Disease in 3 studies

arotinolol: structure given in first source; arotinolol is the (+-)-isomer

Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).

Research Excerpts

ExcerptRelevanceReference
"was given to untreated patients with Graves' disease (n = 16) for 2 weeks."1.29[The effect of arotinolol on the thyroid function and the autonomic nerve systems]. ( Fukasawa, N; Iitaka, M; Ishii, J; Kawakami, Y; Kitahama, S; Miura, S; Sakurai, S, 1993)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, M1
Mori, K1
Nagai, K1
Ito, S1
Fukasawa, N1
Iitaka, M1
Kitahama, S1
Miura, S1
Sakurai, S1
Kawakami, Y1
Ishii, J1
Ohguni, S1
Notsu, K1
Tanaka, J1
Sato, T1
Kato, Y1

Other Studies

3 other studies available for arotinolol and Graves Disease

ArticleYear
Relapse of Graves' disease in a patient with pheochromocytoma.
    Endocrine journal, 2003, Volume: 50, Issue:6

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antithyroid Agen

2003
[The effect of arotinolol on the thyroid function and the autonomic nerve systems].
    Nihon Naibunpi Gakkai zasshi, 1993, Jan-20, Volume: 69, Issue:1

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Animals; Autonomic Nervous System; Cells, Cultured;

1993
[Effect of arotinolol on insulin secretion and insulin clearance rate in patients with Graves' disease].
    Nihon Naibunpi Gakkai zasshi, 1993, Aug-20, Volume: 69, Issue:7

    Topics: Adrenergic beta-Antagonists; Adult; Depression, Chemical; Female; Glucose; Graves Disease; Humans; I

1993